Health TrialsbyHealthPanel

The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program

ConditionsDepression - Major Depressive DisorderAnxiety ChronicAnxietyFunctional OutcomeRecoveryObsessive Compulsive DisordersAssertiveness
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorRakitzi, Stavroula

About this trial

An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association. These 2 above therapy groups will be compared with control groups in a randomized controlled trial

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18-70

Members of the Hellenic Cystic Fibrosis Association

Willingness to participate on 13 sessions via Zoom

Disqualifiers

Age over 70

Not members of the Hellenic Cystic Fibrosis Association

Not able to participate on 13 sessions via Zoom

Trial design

Design model

Parallel

Treatments tested in this trial

  • Group A An online group cognitive behavioral psychotherapy in 13 sessions via Zoom

    Behavioral

    An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy Group A, to patients with cystic fibrosis

  • Group B An online group supportive psychotherapy in 13 sessions via Zoom

    Behavioral

    An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control group Group B, to patients with cystic fibrosis

  • Group C An online group cognitive behavioral psychotherapy in 13 sessions via Zoom

    Behavioral

    An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy group C, to caregivers of patients with cystic fibrosis

  • Group D An online group supportive psychotherapy in 13 sessions via Zoom

    Behavioral

    An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control Group D, to caregivers of patients with cystic fibrosis

Treatment groups

52 Participants
are divided into 4 treatment groups
Group A: Therapy group A patients with Cystic FibrosisExperimental treatment 1 intervention
Group B: Control group B Patients with cystic fibrosisActive comparator 1 intervention
Group C: Therapy group C caregivers of patients with cystic fibrosisExperimental treatment 1 intervention
Group D: Contol group D caregivers of patients with cystic fibrosisActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

SCL-90-R

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

Time frame
Preintervention
2

SCL-90-R

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

Time frame
Immediately after the intervention
3

SCL-90-R

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

Time frame
Follow-up up to 24 weeks
4

SRSDA

It measures Depression. Minimum 0 Maximum over 14. Low scores better

Time frame
Preintervention

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Rakitzi, Stavroula

Lead sponsor

Source ClinicalTrials.gov
Apply now